Blasts More Than 10 Percent of Bone Marrow Nucleated Cells
1 clinical trials · Condition
◉ Watch Blasts More Than 10 Percent of Bone Marrow Nucleated Cells
| Record | Firm | Date |
|---|---|---|
| Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome (NCT04128748) | M.D. Anderson Cancer Center | 2020-05-27 |
Track Blasts More Than 10 Percent of Bone Marrow Nucleated Cells automatically
Every clearance here is in the API, with alerts when new ones post.